Prof. Dr. med. Lars Bullinger
haematology, oncology, leukaemia research, tumor immunology
haematology, oncology, leukaemia research, tumor immunology
Overview
Country, City
Germany, Berlin
Health facility
University Hospital Charite Berlin
Medical unit
Department of oncology, hematology, and tumour immunology
About the doctor
Skills & Expertise
leukemia
myeloid leukemia
acute myeloid leukemia
aml
cancer
chronic lymphocytic leukemia
gene expression
lymphoma
stem cells
chemotherapy
stem cell transplantation
myeloma
multiple myeloma
hematopoiesis
t cells
tumor
oncology
glioblastoma
temozolomide
sarcoma
internal medicine
bone marrow
malignancies
b cell
gemtuzumab
checkpoint inhibition
intensive chemotherapy
colorectal
colorectal cancer
myelofibrosis
gliomas
Resume
CV (Curriculum Vitae)
Education
- 1992-1997 Heidelberg Medical School, Heidelberg, Germany
- 1998 German Academic Exchange Service scholarship
- 1998 Baylor College of Medicine, Houston, and Duke University, Durham, USA
- 1999 MD, Heidelberg Medical School
- 2000 Dr. med. University of Heidelberg
- 2002-2003 German Research Foundation scholarship
- 2002-2003 Postdoctoral fellowship in the department of pathology (Prof. J. D. Pollack), Stanford University, Stanford, CA, USA (DFG scholarship)
- 2008 Habilitation, University of Ulm
Experience
- 2011 Assistant Prof., Internal Medicine, University of Ulm
- 2011-2014 Heisenberg scholarship
- 2016 Associate Prof. of personalized medicine, University of Ulm
- 2017 Full Professor, hematology and oncology, University Hospital Charite, Berlin
- 1999 Residency in the department of internal medicine, hematology and oncology (Prof. A. D. Ho), University of Heidelberg, Germany
- 1999-2001 Residency in the Department of Internal Medicine III (Prof. H. Dohner), University Hospital of Ulm, Germany
- 2004-2009 Residency, fellowship in the department of internal medicine III (Prof. H. Dohner), University Hospital of Ulm, Germany
- 2010 Sabbatical in the department of pediatric oncology (Prof. S. A. Armstrong), Dana Farber Cancer Institute, Harvard Medical School, MA, USA
- 2011-2017 Attending Physician, department of internal medicine III (Prof. H. Dohner), University Hospital of Ulm, Germany
- 2013-2017 Head of the Oncology Section of the department of internal medicine III (Prof. H. Dohner), University Hospital of Ulm, Germany
- 2015 Heisenberg Professor
- 2016-2017 Executive deputy director, the center of internal medicine, University Hospital of Ulm, Germany
- 2016-2017 Professor for personalized medicine, Medical Faculty University of Ulm, Germany
- 2017 Director of the department of hematology, oncology and tumor immunology, University Hospital Charite, Berlin, Germany
Awards & Memberships
- 2005 Franziska Kolb award for leukaemia research
- Member of the American Society of Hematology
- Member of the American Association for Cancer Research
- Member of Working group for internal oncology
- Member of the German Society for Hematology and Oncology
- Member of the German Cancer Society
- Member of the European Hematology Association
- Member of the European LeukemiaNet
Languages
English
German
Publications
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
17 August, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia.
16 August, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia
August, 2023
Location
Charitépl., 1, 10117 Berlin, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Lars Bullinger?
The primary specialization of the doctor is haematology, oncology, leukaemia research, tumor immunology.
What is the experience of the specialist?
Prof. Dr. med. Lars Bullinger has been practicing for more than 27 years.
Prof. Dr. med. Lars Bullinger
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Lars Bullinger